GPCR structuretx.com Net earnings per share for the last 12 months
Structure Therapeutics relies on transparent management and a strong R&D base within the GLP-1 segment. The rolling annual earnings per share snapshot on GURU.Markets contains data where the value of -3.99 serves as the current metric, confirming the company's status as an ambitious innovator in the fight against obesity. High patent barriers and strict FDA requirements protect the company's technological advantage, shutting out smaller players.
%20Earnings%20per%20share%20for%20the%20last%20four%20quarters&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_GPCR_-_Structure-Therapeutics_-_Earnings-per-share-for-the-last-four-quarters "Structure Pharma - GPCR Net earnings per share (EPS TTM) (period 04/28/2023 - 11/11/2026) | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company Structure Therapeutics Inc (GPCR)
- stock price and consensus target price:
- market capitalization data:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
Debt to Equity Structure Therapeutics|GPCR - Long-Term Liabilities to Capital|Short-Term Debt to Equity Structure Pharma|GPCR - Company Debts|Debts to Book Capitalization Structure Therapeutics Inc.|GPCR - Long-Term Debt Volume|Company Short-Term Debt Structure Therapeutics|Quick Liquidity structuretx.com
- net income and valuation multiples indicators:
GPCR - Net Income|Expected Profit Structure Therapeutics|GPCR - Business Payback Period|Projected Price to Earnings Structure Therapeutics Inc.|GPCR - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Structure Therapeutics Inc.|GPCR - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Structure Therapeutics|GPCR - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth structuretx.com|GPCR - Net earnings per share growth this year|Expected earnings per share growth for next year Structure Therapeutics
Fundamental company valuation:Structure Therapeutics (GPCR)
This indicator calculates the aggregate net income over four quarters distributed per common share, allowing for an assessment of real profit generation efficiency regardless of the issuance volume. The negative trend in the 12-month net income per share chart is expected for Structure Therapeutics (GPCR), as colossal development costs for oral GLP-1 agonists temporarily outweigh current revenues.
Competitors of Structure Therapeutics
Ascendis Pharma A/S - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months madrigalpharma.com|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Therapeutics|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (crinetics.com)|Earnings per share for the last twelve months NewAmsterdam Pharma Company N.V. NAMS|Soleno Therapeutics Inc (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|MDXG - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Rezolute|Lexicon Pharmaceuticals Inc (LXRX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MBX Bio (MBX)|Net earnings per share for the last 12 months Altimmune Pharma ALT|Earnings per share for the last twelve months Aardvark Therapeutics Inc AARD|Net earnings per share for the last four quarters sagimet.com (SGMT)|BIOA: Net earnings per share for the last 12 months|Biomea Fusion Inc - Earnings per share for the last four quarters|quincetx.com (QNCX) - Earnings per share for the last twelve months|Fractyl Health, Inc - Earnings per share for the trailing year|Net earnings per share for the last 12 months VTVT|Net earnings per share (EPS TTM) Agape ATP Corp.|Net earnings per share (EPS TTM) PLUR|Net earnings per share for the last 12 months synlogictx.com SYBX|Lipocine Corp - Net earnings per share for the last 12 months|Earnings per share for the last four quarters MTNB (Matinas BioPharma Holdings, Inc.)|SPRB: Net earnings per share for the last 12 months|GLTO - Net earnings per share (EPS TTM)|Carmell (CTCX) - Earnings per share for the last twelve months|Lumos Pharma Inc - Earnings per share for the trailing year|ONVO (Organovo Holdings Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Radius Pharmaceuticals RDUS
